SCHEMBL7685261

SCHEMBL7685261

COC(=O)c1ccc(Cl)cc1N(S(=O)(=O)Cc1ccccc1)S(=O)(=O)Cc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.48
MCOLN3 Q8TDD5 1/20 0.48
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
PLA2G2A P14555 2/20 0.46
ABL1 P00519 1/20 0.45
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
MAPT P10636 2/20 0.42
LTB4R Q15722 1/20 0.41
LTB4R2 Q9NPC1 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
LMNA P02545 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
TMEM97 Q5BJF2 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
PTPN2 P17706 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7699398 0.84 ABL1 (0.51) POLBMCOLN3KDM4EALDH1A1ABL1
SCHEMBL7689230 0.81 POLB (0.48) POLBMCOLN3KDM4EALDH1A1ABL1
SCHEMBL7689485 0.81 POLB (0.48) POLBMCOLN3KDM4EALDH1A1ABL1
SCHEMBL7683236 0.76 MEN1 (0.44) KDM4EALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL7685417 0.76 POLB (0.50) POLBMCOLN3KDM4EALDH1A1ABL1
SCHEMBL8922431 0.75 KDM4E (0.78) POLBKDM4EALDH1A1KMT2AMEN1
SCHEMBL7683091 0.75 GAA (0.57) POLBMCOLN3KDM4EALDH1A1ABL1
SCHEMBL27388939 0.74 ABL1 (0.51) POLBMCOLN3KDM4EPLA2G2AABL1
SCHEMBL6649136 0.72 ABL1 (0.60) POLBMCOLN3KDM4EALDH1A1ABL1
SCHEMBL7556668 0.72 KMT2A (0.64) POLBMCOLN3KDM4EALDH1A1ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020045551-A1 4-benzoyl isoxazoles derivatives and their use as herbicides MUSIL TIBOR (GB) 2002-04-18 US disclosed
US-6323155-B1 EXCELLENT LEVEL OF HERBICIDAL ACTIVITY TOGETHER WITH CROP TOLERANCE RHONE-POULENC AGRICULTURE LIMITED (GB) 2001-11-27 US disclosed
EP-0674629-A1 4-BENZOYL ISOXAZOLES DERIVATIVES AND THEIR USE AS HERBICIDES RHONE-POULENC AGRICULTURE LTD. (GB) 1995-10-04 EP disclosed
WO-1994014782-A1 4-BENZOYL ISOXAZOLES DERIVATIVES AND THEIR USE AS HERBICIDES RHONE-POULENC AGRICULTURE LTD. (GB) 1994-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020045551-A1 4-benzoyl isoxazoles derivatives and their use as herbicides CBR3, CBR1, GLRA3 POLB 2653/4885MCOLN3 2548/4885KDM4E 2527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.